Annual Net Margin
6.93%
+0.18%+2.67%
December 31, 2023
Summary
- As of February 9, 2025, BMRN annual net profit margin is 6.93%, with the most recent change of +0.18% (+2.67%) on December 31, 2023.
- During the last 3 years, BMRN annual net margin has fallen by -38.97% (-84.90%).
- BMRN annual net margin is now -87.33% below its all-time high of 54.70%, reached on December 31, 2010.
Performance
BMRN Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
14.22%
-0.83%-5.51%
September 30, 2024
Summary
- As of February 9, 2025, BMRN quarterly net profit margin is 14.22%, with the most recent change of -0.83% (-5.51%) on September 30, 2024.
- Over the past year, BMRN quarterly net margin has increased by +11.07% (+351.43%).
- BMRN quarterly net margin is now -52.76% below its all-time high of 30.10%, reached on December 31, 2015.
Performance
BMRN Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
BMRN Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.7% | +351.4% |
| 3 y3 years | -84.9% | +66.7% |
| 5 y5 years | +233.8% | +66.7% |
BMRN Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +299.7% | -38.9% | +210.5% |
| 5 y | 5-year | -84.9% | +299.7% | -38.9% | +210.5% |
| alltime | all time | -87.3% | +100.7% | -52.8% | +100.1% |
BioMarin Pharmaceutical Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 14.22%(-5.5%) |
| Jun 2024 | - | 15.05%(+10.2%) |
| Mar 2024 | - | 13.66%(+333.7%) |
| Dec 2023 | 6.93%(+2.7%) | 3.15%(-54.7%) |
| Sep 2023 | - | 6.95%(-26.1%) |
| Jun 2023 | - | 9.41%(+10.3%) |
| Mar 2023 | - | 8.53%(<-9900.0%) |
| Dec 2022 | 6.75%(-294.5%) | -0.05%(-96.2%) |
| Sep 2022 | - | -1.32%(-125.5%) |
| Jun 2022 | - | 5.18%(-77.7%) |
| Mar 2022 | - | 23.26%(-280.7%) |
| Dec 2021 | -3.47%(-107.6%) | -12.87%(+44.1%) |
| Sep 2021 | - | -8.93%(-446.1%) |
| Jun 2021 | - | 2.58%(-27.7%) |
| Mar 2021 | - | 3.57%(-5.3%) |
| Dec 2020 | 45.90%(-3378.6%) | 3.77%(-155.5%) |
| Jun 2020 | - | -6.79%(-141.9%) |
| Mar 2020 | - | 16.21%(+389.7%) |
| Dec 2019 | -1.40%(-73.0%) | 3.31%(-72.3%) |
| Sep 2019 | - | 11.94%(-223.7%) |
| Jun 2019 | - | -9.65%(-31.5%) |
| Mar 2019 | - | -14.09%(+1268.0%) |
| Dec 2018 | -5.18%(-41.9%) | -1.03%(-68.0%) |
| Sep 2018 | - | -3.22%(-28.4%) |
| Jun 2018 | - | -4.50%(-61.9%) |
| Mar 2018 | - | -11.82%(-17.6%) |
| Dec 2017 | -8.91%(-84.2%) | -14.34%(+282.4%) |
| Sep 2017 | - | -3.75%(-67.7%) |
| Jun 2017 | - | -11.60%(+116.4%) |
| Mar 2017 | - | -5.36%(-82.3%) |
| Dec 2016 | -56.43%(+192.2%) | -30.23%(+126.1%) |
| Sep 2016 | - | -13.37%(-90.4%) |
| Jun 2016 | - | -139.61%(+298.0%) |
| Mar 2016 | - | -35.08%(-216.5%) |
| Dec 2015 | -19.31%(+8.0%) | 30.10%(-169.1%) |
| Sep 2015 | - | -43.53%(+32.8%) |
| Jun 2015 | - | -32.78%(-1.4%) |
| Mar 2015 | - | -33.26%(+9.6%) |
| Dec 2014 | -17.88%(-44.4%) | -30.34%(-819.0%) |
| Sep 2014 | - | 4.22%(-124.2%) |
| Jun 2014 | - | -17.47%(-30.5%) |
| Mar 2014 | - | -25.15%(-40.4%) |
| Dec 2013 | -32.15%(+40.8%) | -42.21%(+9.0%) |
| Sep 2013 | - | -38.74%(+146.1%) |
| Jun 2013 | - | -15.74%(-49.4%) |
| Mar 2013 | - | -31.12%(-22.5%) |
| Dec 2012 | -22.84% | -40.18%(+861.2%) |
| Sep 2012 | - | -4.18%(-83.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | -25.81%(+25.6%) |
| Mar 2012 | - | -20.55%(-17.1%) |
| Dec 2011 | -12.20%(-122.3%) | -24.79%(+59.3%) |
| Sep 2011 | - | -15.56%(+239.0%) |
| Jun 2011 | - | -4.59%(+15.0%) |
| Mar 2011 | - | -3.99%(-66.8%) |
| Dec 2010 | 54.70%(<-9900.0%) | -12.00%(+2207.7%) |
| Jun 2010 | - | -0.52%(-138.5%) |
| Mar 2010 | - | 1.35%(-75.0%) |
| Dec 2009 | -0.15%(-101.4%) | 5.41%(-34.2%) |
| Sep 2009 | - | 8.22%(+420.3%) |
| Jun 2009 | - | 1.58%(-108.9%) |
| Mar 2009 | - | -17.78%(-172.0%) |
| Dec 2008 | 10.40%(-180.0%) | 24.68%(+2064.9%) |
| Sep 2008 | - | 1.14%(-80.8%) |
| Jun 2008 | - | 5.94%(+112.9%) |
| Mar 2008 | - | 2.79%(-51.3%) |
| Dec 2007 | -13.00%(-61.6%) | 5.73%(-127.5%) |
| Sep 2007 | - | -20.86%(+55.9%) |
| Jun 2007 | - | -13.38%(-67.1%) |
| Mar 2007 | - | -40.69%(-13.8%) |
| Dec 2006 | -33.88%(-88.3%) | -47.19%(+67.2%) |
| Sep 2006 | - | -28.23%(+399.6%) |
| Jun 2006 | - | -5.65%(-92.0%) |
| Mar 2006 | - | -70.81%(-55.3%) |
| Dec 2005 | -289.34%(-71.2%) | -158.27%(-22.5%) |
| Sep 2005 | - | -204.20%(-65.3%) |
| Jun 2005 | - | -588.53%(+30.7%) |
| Mar 2005 | - | -450.15%(-24.1%) |
| Dec 2004 | -1005.54%(+60.5%) | -593.09%(-96.4%) |
| Sep 2004 | - | -16.29 K%(+1236.6%) |
| Jun 2004 | - | -1218.45%(+1520.7%) |
| Dec 2003 | -626.43%(+62.9%) | - |
| Jun 2003 | - | -75.18%(-84.3%) |
| Sep 2002 | - | -479.38%(+13.9%) |
| Jun 2002 | - | -421.01%(-40.0%) |
| Mar 2002 | - | -701.56%(+138.5%) |
| Sep 2001 | - | -294.20%(-26.0%) |
| Jun 2001 | - | -397.38%(+10.2%) |
| Mar 2001 | - | -360.59%(-81.8%) |
| Dec 2000 | -384.64%(-27.4%) | -1976.05%(+580.8%) |
| Sep 2000 | - | -290.27%(+26.3%) |
| Jun 2000 | - | -229.84%(-35.4%) |
| Mar 2000 | - | -355.85%(-76.5%) |
| Dec 1999 | -529.66%(-48.3%) | -1512.00%(+297.9%) |
| Sep 1999 | - | -380.00%(-10.6%) |
| Jun 1999 | - | -425.00%(+1.8%) |
| Mar 1999 | - | -417.48% |
| Dec 1998 | -1025.00% | - |
FAQ
- What is BioMarin Pharmaceutical annual net profit margin?
- What is the all time high annual net margin for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual net margin year-on-year change?
- What is BioMarin Pharmaceutical quarterly net profit margin?
- What is the all time high quarterly net margin for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly net margin year-on-year change?
What is BioMarin Pharmaceutical annual net profit margin?
The current annual net margin of BMRN is 6.93%
What is the all time high annual net margin for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual net profit margin is 54.70%
What is BioMarin Pharmaceutical annual net margin year-on-year change?
Over the past year, BMRN annual net profit margin has changed by +0.18% (+2.67%)
What is BioMarin Pharmaceutical quarterly net profit margin?
The current quarterly net margin of BMRN is 14.22%
What is the all time high quarterly net margin for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly net profit margin is 30.10%
What is BioMarin Pharmaceutical quarterly net margin year-on-year change?
Over the past year, BMRN quarterly net profit margin has changed by +11.07% (+351.43%)